DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis

References

• Sarkar S. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. Bioch Soc Trans. 2013;41:1103–1130.
   PubMed Web of Science ®Google Scholar
• Boland B, Kumar A, Lee S, et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease. J Neurosci. 2008;28:2937–6926.
   Web of Science ®Google Scholar
• Banerjee R, Beal MF, Thomas B. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci. 2010;33:541–549.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Shojaei S, Yeganeh B, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24–49.
   PubMed Web of Science ®Google Scholar
• Merenlender-Wagner A, Malishkevich A, Shemer Z, et al. Autophagy has a key role in the pathophysiology of schizophrenia. Mol Psychiatry. 2015;20:126–132.
   PubMed Web of Science ®Google Scholar
• Jia J, Le W. Molecular network of neuronal autophagy in the pathophysiology and treatment of depression. Neurosci Bull. 2015;31:427–434.
   PubMed Web of Science ®Google Scholar
• Ravikumar B, Vacher C, Berger Z, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36:585–595.
   PubMed Web of Science ®Google Scholar
• Rose C, Menzies FM, Renna M, et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington’s disease. Hum Mol Genet. 2010;19:2144–2153.
   PubMed Web of Science ®Google Scholar
• Metcalf DJ, García-Arencibia M, Hochfeld WE, et al. Autophagy and misfolded proteins in neurodegeneration. Exp Neurol. 2012;238:22–28.
   PubMed Web of Science ®Google Scholar
• Mariño G, Niso-Santano M, Baehrecke EH, et al. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15:81–94.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu J, Pan H, et al. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci USA. 2007;104:19023–19028.
   PubMed Web of Science ®Google Scholar
• Wang JD, Cao YL, Li Q, et al. A pivotal role of FOS-mediated BECN1/Beclin1 upregulation in dopamine D2 and D3 receptor agonist-induced autophagy activation. Autophagy. 2015;11:2057–2073.
   PubMed Web of Science ®Google Scholar
• Wei C, Gao J, Li M, et al. Dopamine D2 receptors contribute to cardioprotection of ischemic post-conditioning via activating autophagy in isolated rat hearts. Int J Cardiol. 2016;203:837–839.
   PubMed Web of Science ®Google Scholar
• Yan H, Li WL, Xu JJ, et al. D2 dopamine receptor antagonist raclopride induces non-canonical autophagy in cardiac myocytes. J Cell Biochem. 2013;114:103–110.
   PubMed Web of Science ®Google Scholar
• Ling ZD, Robie HC, Tong CW, et al. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures. J Pharmacol Exp Ther. 1999;289:202–210.
   PubMed Web of Science ®Google Scholar
• Li M, Yang Z, Vollmer LL, et al. AMDE-1 is a dual function chemical for autophagy activation and inhibition. PLoS One. 2015;10:e0122083.
   PubMed Web of Science ®Google Scholar
• Li Y, McGreal S, Zhao J, et al. A cell-based quantitative high-throughput image screening identified novel autophagy modulators. Pharmacol Res. 2016;110:35–49.
   PubMed Web of Science ®Google Scholar
• Meador-Woodruff JH, Damask SP, Wang J, et al. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 1996;15:17–29.
   PubMed Web of Science ®Google Scholar
• Diaz J, Pilon C, Le Foll B, et al. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci. 2000;20:8677–8684.
   PubMed Web of Science ®Google Scholar
• Araki KY, Sims JR, Bhide PG. Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development. Brain Res. 2007;1156:31–45.
   PubMed Web of Science ®Google Scholar
• Joyce JN, Millan MJ. Dopamine D3 receptor agonists for protection and repair in Parkinson’s disease. Curr Opin Pharmacol. 2007;7:100–105.
   PubMed Web of Science ®Google Scholar
• Rao NP, Remington G. Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials. Expert Opin Pharmacother. 2014;15:373–383.
   PubMed Web of Science ®Google Scholar
• Moritz AE, Benjamin Free R, Sibley DR. Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds. Cell Signal. 2018;41:75–81.
   PubMed Web of Science ®Google Scholar
• Antonini A, Barone P, Ceravolo R, et al. Role of pramipexole in the management of Parkinson’s disease. CNS Drugs. 2010;23:829–841.
   Google Scholar
• Zarate CA Jr, Payne JL, Singh J, et al. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry. 2004;56:54–60.
   PubMed Web of Science ®Google Scholar
• Fawcett J, Rush AJ, Vukelich J, et al. Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression. Am J Psychiatry. 2016;173:107–111.
   PubMed Web of Science ®Google Scholar
• Li C, Guo Y, Xie W, et al. Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson’s disease. Neurochem Res. 2010;35:1546–1556.
   PubMed Web of Science ®Google Scholar
• Salles MJ, Hervé D, Rivet JM, et al. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens. J Neurochem. 2013;125:532–544.
   PubMed Web of Science ®Google Scholar
• Mannoury La Cour C, MJ S, Pasteau V, et al. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D2 and D3 receptors. Mol Pharmacol. 2011;79:91–105.
   PubMed Web of Science ®Google Scholar
• Zapata A, Kivell B, Han Y, et al. Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem. 2007;282:35842–35854.
   PubMedGoogle Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1–222.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3:542–545.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Levine N. Methods in mammalian autophagy research. Cell. 2010;140:313–326.
   PubMed Web of Science ®Google Scholar
• Streeter A, Menzies FM, Rubinsztein DC. LC3-II Tagging and western blotting for monitoring autophagic activity in mammalian cells. Methods Mol Biol. 2016;1303:161–170.
   PubMedGoogle Scholar
• Bjorkoy G, Lamark T, Pankiv S, et al. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009;452:181–197.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biol. 2011;13:131–141.
   Web of Science ®Google Scholar
• Menon MB, Beclin DS. 1 phosphorylation - at the center of autophagy regulation. Front Cell Dev Biol. 2018;6:137. e Collection 2018.
   PubMed Web of Science ®Google Scholar
• Foster KG, Fingar DC. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem. 2010;285:14071–14077.
   PubMed Web of Science ®Google Scholar
• Pearson RB, Dennis PB, Han JW, et al. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. Embo J. 1995;14:5279–5287.
   PubMed Web of Science ®Google Scholar
• Copp J, Manning G, Hunter T. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 2009;69:1821–1827.
   PubMed Web of Science ®Google Scholar
• Hardie DG. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes. 2008;32(Suppl 4):S7–S12.
   PubMed Web of Science ®Google Scholar
• Hawley SA, Davison M, Woods A, et al. Characterization of the AMP-activated protein kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem. 1996;271:27879–27887.
   PubMed Web of Science ®Google Scholar
• Tamargo-Gomez I, Mariño G. AMPK: regulation of metabolic dynamics in the context of autophagy. Int J Mol Sci. 2018;19:pii: E3812.
   PubMed Web of Science ®Google Scholar
• Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;331:456–461.
   Google Scholar
• Lee JW, Park S, Takahashi Y, et al. The association of AMPK with ULK regulates autophagy. PLoS One. 2010;5:e15394.
   PubMed Web of Science ®Google Scholar
• Kim DH, Sarbassov DD, Ali SM, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110:163–175.
   PubMed Web of Science ®Google Scholar
• Sutton LP, Caron MG. Essential role of D1R in the regulation of mTOR complex 1 signaling induced by cocaine. Neuropharmacology. 2015;99:610–619.
   PubMed Web of Science ®Google Scholar
• Xu S, Kang UG. Region-specific activation of the AMPK system by cocaine: the role of D1 and D2 receptors. Pharmacol Biochem Behav. 2016;146-147:28–38.
   PubMed Web of Science ®Google Scholar
• Maiese K. targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol. 2016;82:1245–1266.
   PubMed Web of Science ®Google Scholar
• Sultana R, Perluigi M, Butterfield DA. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med. 2013;62:157–169.
   PubMed Web of Science ®Google Scholar
• Qin X, Jiang B, Zhang Y. 4E-BP1, a multifactor regulated multifunctional protein. Cell Cycle. 2016;15:781–786.
   PubMed Web of Science ®Google Scholar
• Meyuhas O. Ribosomal protein S6 phosphorylation: four decades of research. Int Rev Cell Mol Biol. 2015;320:41–73.
   PubMed Web of Science ®Google Scholar
• Roux PP, Shahbazian D, Vu H, et al. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem. 2007;282:14056–14064.
   PubMed Web of Science ®Google Scholar
• Ayuso MI, Hernández-Jiménez M, Martín ME, et al. New hierarchical phosphorylation pathway of the translational repressor eIF4E-binding protein 1 (4E-BP1) in ischemia-reperfusion stress. J Biol Chem. 2010;285:34355–34363.
   PubMed Web of Science ®Google Scholar
• Thoreen CC, Kang SA, Chang JW, et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem. 2009;284:8023–8032.
   PubMed Web of Science ®Google Scholar
• Brunn GJ, Hudson CC, Sekulic A, et al. Phosphorylation of the translational repressor PHA-l by the mammalian target of rapamycin. Science. 1997;277:99–101.
   PubMed Web of Science ®Google Scholar
• Luis-Ravelo D, Estévez-Silva H, Barroso-Chinea P, et al. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington’s disease. Exp Neurol. 2018;299:137–147.
   PubMed Web of Science ®Google Scholar
• Piercey MF, Hoffmann WE, Smith MW, et al. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists. Eur J Pharmacol. 1996;312:35–44.
   PubMed Web of Science ®Google Scholar
• Sokoloff P, Giros B, Martres MP, et al. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347:146–151.
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Gainetdinov RR. The physiology, signalling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63:182–217.
   PubMed Web of Science ®Google Scholar
• Jin M, Min C, Zheng M, et al. Multiple signalling routes involved in the regulation of adenylyl cyclase and extracellular regulated kinase by dopamine D(2) and D(3) receptors. Pharmacol Res. 2013;67:31–41.
   PubMed Web of Science ®Google Scholar
• Cho EY, Cho DI, Park JH, et al. Roles of protein kinase C and actin-binding protein 280 in the regulation of intracellular trafficking of dopamine D3 receptor. Mol Endocrinol. 2007;21:2242–2254.
   PubMedGoogle Scholar
• Min C, Zheng M, Zhang X, et al. Novel roles of β-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors. Br J Pharmacol. 2013;170:1112–1129.
   PubMed Web of Science ®Google Scholar
• Collo G, Bono F, Cavalleri L, et al. Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling. Mol Pharmacol. 2013;83:1176–11189.
   PubMed Web of Science ®Google Scholar
• Cavalleri L, Merlo Pich E, Millan MJ, et al. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling. Mol Psychiatry. 2018;23:812–823.
   PubMed Web of Science ®Google Scholar
• Francipane MG, Lagasse E. Therapeutic potential of mTOR inhibitors for targeting cancer stem cells. Br J Clin Pharmacol. 2016;82:1180–1188.
   PubMed Web of Science ®Google Scholar
• Baroja-Mazo A, Revilla-Nuin B, Ramirez P, et al. Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation. World J Transplant. 2016;6:183–192.
   PubMedGoogle Scholar
• Habbib A, Finn AV. Antiproliferative drugs for restenosis prevention. Interv Cardiol Clin. 2016;5:321–329.
   PubMedGoogle Scholar
• Caccamo A, Majumder S, Richardson A, et al. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010;285:13107–13120.
   PubMed Web of Science ®Google Scholar
• Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84:275–291.
   PubMed Web of Science ®Google Scholar
• Bockaert J, Marin P. mTOR in brain physiology and pathologies. Physiol Rev. 2015;95:1157–1187.
   PubMed Web of Science ®Google Scholar
• Ben-Sahra I, Manning BD. mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol. 2017;45:72–82.
   PubMed Web of Science ®Google Scholar
• Mishra P, Dauphinee AN, Ward C, et al. Discovery of pan autophagy inhibitors through a high-throughput screen highlights macroautophagy as an evolutionarily conserved process across 3 eukaryotic kingdoms. Autophagy. 2017;13:1556–1572.
   PubMed Web of Science ®Google Scholar
• Chauvin C, Koka V, Nouschi A, et al. Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program. Oncogene. 2014;33:474–483.
   PubMed Web of Science ®Google Scholar
• Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci. 2011;36:320–328.
   PubMed Web of Science ®Google Scholar
• Roux PP, Ballif BA, Anjum R, et al. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA. 2004;101:13489–13494.
   PubMed Web of Science ®Google Scholar
• Greenberg VL, Zimmer SG. Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through Cdk-1dependent mechanism. Oncogene. 2005;24:4851–4860.
   PubMed Web of Science ®Google Scholar
• Shin S, Wolgamott L, Tcherkezian J, et al. Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1. Oncogene. 2014;33:1690–1699.
   PubMed Web of Science ®Google Scholar
• Mengod G, Villaró MT, Landwehrmeyer GB, et al. Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem Int. 1992;20:33S–43S.
   PubMed Web of Science ®Google Scholar
• Maggio R, Scarselli M, Capannolo M, et al. Novel dimensions of D3 receptor function: focus on heterodimerisation, transactivation and allosteric modulation. Eur Neuropsychopharmacol. 2015;25:1470–1479.
   PubMed Web of Science ®Google Scholar
• Murray AM, Ryoo HL, Gurevich E, et al. Localization of dopamine D3 to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA. 1994;91:11271–11275.
   PubMed Web of Science ®Google Scholar
• Giovannini MG, Lana D, Pepeu G. The integrated role of Ach, ERK and mTOR in the mechanisms of hippocampal inhibitory avoidance memory. Neurobiol Learn Mem. 2015;119:18–33.
   PubMed Web of Science ®Google Scholar
• Karl T, Garner B, Cheng D. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease. Behav Pharmacol. 2017;28:142–160.
   PubMed Web of Science ®Google Scholar
• Boland B, Yu WH, Corti O, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018;17:660–688.
   PubMed Web of Science ®Google Scholar
• Granado N, Ares-Santos S, Oliva I, et al. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Dis. 2011;42:391–403.
   PubMed Web of Science ®Google Scholar
• Accili D, Fishburn CS, Drago J, et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA. 1996;93:1945–1949.
   PubMed Web of Science ®Google Scholar
• Kowalski C, Giraud P. Dopamine decreases striatal enkephalin turnover and proenkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures. Neuroscience. 1993;53:665–672.
   PubMed Web of Science ®Google Scholar
• Jeanneteau F, Diaz J, Sokoloff P, et al. Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors. Mol Biol Cell. 2004;15:696–705.
   PubMed Web of Science ®Google Scholar
• Guo S, Liang Y, Murphy SF, et al. A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications. Autophagy. 2015;11:560–572.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu Y, Stoleru D, et al. Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin. Proc Natl Acad Sci USA. 2012;109:213–218.
   Web of Science ®Google Scholar
• Kikugawa K, Kojima T, Yamaki S, et al. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid. Anal Biochem. 1992;202:249–255.
   PubMed Web of Science ®Google Scholar
• Valenzuela A. The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci. 1991;48:301–309.
   PubMed Web of Science ®Google Scholar